Immune-Mediated Inflammatory Diseases

We focus on research related to immune-mediated inflammatory diseases (IMID), providing customers with comprehensive drug development and preclinical evaluation services. IMIDs encompass a range of common diseases characterized by diverse clinical phenotypes and currently lacking curative treatments. Examples include rheumatoid arthritis (RA), spondyloarthritis (SpA), connective tissue diseases, inflammatory skin diseases (including psoriasis and atopic dermatitis), inflammatory bowel disease (IBD), asthma, and autoimmune neurological diseases such as multiple sclerosis. We deeply understand the shared underlying pathogenesis of IMIDs as well as the unique pathways of specific diseases. We can provide customized model construction, drug screening, efficacy evaluation, and mechanism of action studies based on the clinical phenotype, age and sex distribution, tissue localization, and treatment response characteristics of different diseases. Our experienced research team will provide you with high-quality data, professional experimental reports, and in-depth scientific interpretations, helping to advance your IMID research and accelerate the innovative drug development process.

1. Imiquimod-Induced Murine Model of Psoriasis Dermatitis:

2. DSS-Induced Murine Model of Ulcerative Colitis

3. Murine Collagen-Induced Arthritis (CIA) Model:

4. MSU-Induced Rat Model of Acute Gouty Arthritis:

5. TPA-Induced Murine Model of Ear Edema